Skip to main content

Table 1 Clinicopathological features (n = 155)

From: Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma

  n %
Age   
   ≤ 45 years 61 39,4
   > 45 years 94 60,6
Tumor size   
   ≤ 50 mm 118 76,1
   > 50 mm 37 23,9
Tumor grade   
   1 17 11
   2 98 63,2
   3 40 25,8
Histologic type   
   Ductal 130 83.8
   Non ductal 25 16.1
Lymph node   
   Negative 90 58,1
   Positive 65 41,9
ER expression   
   Negative 63 40,6
   Positive 92 59,4
PR expression   
   Negative 73 47,1
   Positive 81 52,3
HER-2 status   
   Negative (score 0, 1, 2+) 127 81,9
   Positive (score 3+) 28 18,1
Surgery   
   MRM 88* 81.4*
   BCS 18* 16.6*
   MWAC 2* 1.8*
Systemic therapy 92* 85.1*
Radiotherapy 76* 70.3*
Hormone therapy 46* 42.5*
  1. HER-2: Human epidermal growth factor receptor 2; ER: Estrogen receptor; PR: Progesterone receptor; MRM: modified radical mastectomy; BCS: breast conserving surgery; MWAC: Mastectomy without axillary clearance. *: n = 108.